Spire Healthcare Group (SPI) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
8 Jul, 2026Market opportunity and strategic rationale
Primary care market is large, fast-growing, and fragmented, with significant growth rates across segments such as occupational health (6%), GP services (10%), diagnostics (2%), outpatient treatments (10%), physiotherapy (4%), and talking therapies (10%).
The business aims to complement its hospital operations by building a scalable, standalone primary care platform, leveraging synergies and cross-referrals.
Integration of acquired businesses (Vita Health Group and Doctors Clinic Group) has created a national network for GP, physio, and talking therapies, targeting NHS, corporate, and B2C customers.
The strategy focuses on early patient engagement, cross-pollination of services, and leveraging a sophisticated data-driven model for clinic location selection.
Occupational health is being repositioned from advice-only to intervention-based, addressing two-thirds of workplace absences (MSK and mental health).
Financial targets and growth drivers
Current EBITDA is over £10 million, with a medium-term ambition to reach £40 million, supported by organic growth, new contracts, and M&A.
Organic growth is expected to continue at historical rates, with new clinics contributing more significantly from 2027 onwards.
M&A is focused on small, accretive deals, especially in occupational health and clinics, to build a national footprint and enhance service integration.
Double-digit EBITDA margins are targeted in the medium term, with stronger EBIT drop-through due to a capital-light model.
NHS contracts typically run for 5–7 years, providing revenue visibility and stability; recent renewals have extended contract durations.
Service offering and operational model
Four main service lines: talking therapies, physiotherapy, occupational health, and GP services, with a growing dermatology segment linked to mental health.
Talking therapies are 80–90% remote, supporting a capital-light, scalable model; physio and occupational health also leverage remote delivery.
GP services are primarily out-of-pocket B2C, with some PMI and corporate contracts; currently fee-for-service, with potential for capitation models.
Clinic rollout strategy uses a gravity model to optimize locations near hospitals and patient populations, with minimal CapEx per room (£30,000–£40,000).
Operational synergies are realized through shared back-office functions, marketing, and buying power, while maintaining separate clinical operations.
Latest events from Spire Healthcare Group
- FY26 adjusted EBITDA is expected to match FY25, with strong private and NHS revenue growth.SPI
Trading update14 May 2026 - Strong cash flow and private growth offset NHS slowdown; 2026 outlook cautious.SPI
H2 20255 Mar 2026 - Double-digit revenue and earnings growth, margin expansion, and robust outlook for 2024.SPI
H1 202420 Jan 2026 - Revenue growth, cost savings, and strategic review position the group for stable FY26 performance.SPI
Trading Update3 Dec 2025 - Strong 2024 revenue and margin growth, with robust efficiencies and positive 2025 outlook.SPI
H2 20241 Dec 2025 - Revenue and EBITDA rose, with transformation and NHS growth supporting a strong outlook.SPI
H1 202516 Nov 2025 - 2025 trading meets expectations, with efficiency gains and NHS partnerships driving growth.SPI
Trading Update6 Jun 2025